Submitted by Anonymous (not verified) on 9 April 2026 - 16:38
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cablivi, caplacizumab, Date of authorisation: 30/08/2018, Revision: 11, Status: Authorised